跳至主要内容
临床试验/NCT05570279
NCT05570279进行中(未招募)不适用

PLAN-A - Data- Bio-and Plan-bank Collection in Patients Treated With Radiotherapy for Squamous Cell Carcinoma of the Anus in Denmark - a DACG Cooperation

Aarhus University Hospital3 个研究点 分布在 1 个国家目标入组 314 人开始时间: 2016年4月1日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
314
试验地点
3
主要终点
Complete clinical response

研究概览

简要总结

The study is a prospective registration of treatment related-, toxicity-, Quality of life- and outcome data from patients treated in Denmark with radiotherapy for squamous cell carcinoma of the anus (SCCA), as a cooperation within the Danish Anal Cancer Group (DACG).

Substudy one: A prospective biobank is collected with the purpose to identify predictive and prognostic markers for outcome.

Substudy two: MRI scans are performed to investigate the rate of pelvic insufficience fractures at one year post chemoradiotherapy.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Squamous cell carcinoma of the anus, and indication for curatively intended radiotherapy
  • Written and oral consent

排除标准

  • Contraindication to blood sampling or MRI scans (substudy 1 and 2)
  • Other malignant disease within 5 years except from basal cell carcinomas

结局指标

主要结局

Complete clinical response

时间窗: 3 years

Rate of complete response to primary treatment as defined by clinical and radiological evaluation

次要结局

  • Early toxicity evaluation by CTCAE(2 weeks after the last day of therapy)
  • Late toxicity evaluation by CTCAE(1 and 3 years post treatment)
  • Quality of life assessed by the EORTC QoL questionaires(2 weeks, 1 and 3 years post therapy)
  • Prognostic value of ctDNA(At time of treatment completion, an average of 30 days, 1 and 3 years post therapy)
  • Incidence of pelvis fractures(1 and 3 years post therapy)

研究者

发起方
Aarhus University Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Karen-Lise Garm Spindler

Professor

Aarhus University Hospital

研究点 (3)

Loading locations...

相似试验